ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
05 Jul 2016 09:24

What the IPOs Completed in Korea Stock Exchange in 1H 2016 Reveal....

If you want to outperform the market, perhaps you should take a look at the IPO market in Korea. In the midst of difficult global IPO markets, the...

Logo
293 Views
Share
bearishCelltrion Inc
12 Jun 2016 03:20

Study Highlights Hurdles to U.S. Uptake of Inflectra

A new study (abstract attached) presented at the European Union League Against Rheumatism (EULAR) Conference highlights one of the main hurdles to...

Share
31 May 2016 15:45

Korea Stock Market Monthly Recap #2 - (May 2016)

Our portfolio of top picks were up on average 9.5% in May versus KOSPI which was down 0.5% in the same period.  Our top picks in the Korean...

Logo
183 Views
Share
bearishCelltrion Inc
17 May 2016 10:20

Why Be Optimistic if the Payers Are Cautious?

Recent comments from one of the largest health insurers in the U.S. reinforce our view that management's expectations for Remsima (U.S. name...

Share
14 May 2016 07:55

What's All the Fuss About Quantitative Easing in Korea?

There have been lots of discussions in Korea's media about Korea's version of Quantitative Easing in the past several weeks, especially after...

Logo
182 Views
Share
x